(Press-News.org) STANFORD, Calif. — Many patients with rheumatoid arthritis, a crippling disease that causes pain, swelling and eats away at the joints, aren't receiving the much-needed, low-cost medications that can prevent deformity.
Despite medical guidelines recommending that patients receive early and aggressive treatment for rheumatoid arthritis with these medications, only 63 percent of Medicare-managed care patients diagnosed with the disease received any amount of the prescription drugs, according to a new study led by a researcher from the Stanford University School of Medicine that will be published Feb. 2 in the Journal of the American Medical Association.
"Among patients with a true diagnosis of rheumatoid arthritis, closer to 90 percent should be receiving treatment," said Gabriela Schmajuk, MD, a postdoctoral scholar in the Division of Immunology and Rheumatology and lead author of the study. The study's senior author is Jinoos Yazdany, MD, MPH, adjunct assistant professor of rheumatology at the University of California-San Francisco.
Which patients receive these medications also varies dramatically by their health-care plan, their economic status and where they live, the study found.
The medications, called disease-modifying antirheumatic drugs or DMARDs, have long been available, but in the past 12 or 13 years many more new versions of the drugs have entered the market. Costs range from many thousands of dollars per year for some of the newer medications to a few hundred dollars for a year of treatment with some of the older drugs.
"We counted patients who received the bare minimum amount of treatment, and still a large proportion of patients aren't getting the medication they need," said Schmajuk. "We set the bar very low."
Rheumatoid arthritis is a chronic, painful disease that leads to inflammation of the joints and surrounding tissues. The cause is unknown, but it's considered an autoimmune disease. The body's immune system, instead of attacking foreign substances such as viruses, turns on itself. About 1.3 million Americans have rheumatoid arthritis and three-fourths of them are women. There is no known cure, and it usually strikes between the ages of 30 and 60.
"The reason treatment is so important is that if left untreated one-third of patients with rheumatoid arthritis will become disabled within five years of diagnosis," Schmajuk said. "The disease primarily affects the hands. Frequently patients are unable to work because they can't use their hands."
The study examined variations in medication treatment of 93,143 patients with rheumatoid arthritis who were at least 65 years old between 2005 and 2008. The researchers got the information from the Centers for Medicare and Medicaid HEDIS database.
HEDIS is a widely used set of performance measurements in the managed-care industry developed and maintained by the National Committee for Quality Assurance. It was designed to allow consumers to compare a health plan's performance with other plans and to national and regional benchmarks. In 2005, the database added reporting of the receipt of DMARDS among patients with rheumatoid arthritis.
Commercial health plans participate voluntarily in reporting to the database, but Medicare-managed care plans are required to report results.
"We found that certain groups were not receiving the medication they needed," Schmajuk said. "Patients who had low income received DMARDs less frequently than wealthier patients. Blacks received medications less frequently than whites. We also found that patients who lived in the mid- and south-Atlantic regions received medications less frequently than other areas, particularly the West Coast states."
Researchers also found that treatment varied dramatically between health-care plans.
"Some plans were doing really well with over 80 percent of patients being treated appropriately," Schmajuk said. "Others plans had fewer than 20 percent of patients getting appropriate care, which is really worrisome. We know this wasn't because of the individual characteristics of patients since the health plan results were adjusted for age, race, income and geographic region."
The database included about 300 different health-care plans nationwide. Researchers didn't investigate the causes of the variations in treatment and could only speculate.
"Some health plans might have different policies about when patients can see certain specialists," Schmajuk said. "Or one health-care plan might have one rheumatologist for 5,000 patients versus another that provides one for every 500 patients."
###
Consumers can search for the reported results from Medicare-managed care plans at http://www.ncqa.org.
Eliza Chakravarty, MD, assistant professor of immunology and rheumatology at Stanford, was a co-author of the study. Other authors who contributed to the study were from UCSF, Brown University and Harvard University.
Funding was provided by the American College of Rheumatology/Research and Education Foundation Physician-Scientist Development Award; National Center for Research Resources; Rosalind Russell Medical Research Center for Arthritis; National Institutes of Health; State of California Lupus Fund; Arthritis Foundation; Agency for Healthcare Research and Quality; and National Institute of Arthritis and Musculoskeletal and Skin Diseases.
More information about Stanford's Department of Medicine, which supported the study, is available at http://medicine.stanford.edu/.
The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit http://mednews.stanford.edu. The medical school is part of Stanford Medicine, which includes Stanford Hospital & Clinics and Lucile Packard Children's Hospital. For information about all three, please visit http://stanfordmedicine.org/about/news.html.
PRINT MEDIA CONTACT: Tracie White at (650) 723-7628 (traciew@stanford.edu)
BROADCAST MEDIA CONTACT: M.A. Malone at (650) 723-6912 (mamalone@stanford.edu)
END
A parent's wise advice to never go to a hospital unless you want to get sick may be gaining support from scientific studies on a specific airborne virus.
The results of a Virginia Tech study by environmental engineers and a virologist on the risk of airborne infection in public places from concentrations of influenza A viruses is appearing today in the on-line, Feb. 2 issue of the United Kingdom's Journal of the Royal Society Interface.
Linsey Marr, associate professor of civil and environmental engineering at Virginia Tech, http://www.cee.vt.edu/people/lmarr.html and ...
SAN FRANCISCO–German researcher Claus Cursiefen, MD, also affiliated with Harvard School of Medicine, reports good results with a new surgical strategy that uses a single donor cornea to help two patients with differing corneal diseases. In the United States keeping pace with demand for donated corneal tissue for use in transplant surgery is a cause for concern, while in Europe and Asia shortages lead to treatment delays. Dr. Cursiefen's new approach restored good vision to patients who had Fuchs' dystrophy (degeneration of certain corneal cells) or keratoconus (thin, cone-shaped ...
If you're a woman and your mother had a stroke, you may have a risk of heart attack in addition to a higher risk of stroke, according to new research on family history and heart disease published in the American Heart Association journal Circulation: Cardiovascular Genetics.
In a study of more than 2,200 patients, female heart patients were more likely to have mothers who had suffered a stroke than fathers who did.
"Our study results point towards sex-specific heritability of vascular disease across different arterial territories — namely coronary and cerebral artery ...
An examination of data from a nationally representative sample of patients discharged from hospices demonstrated that compared with nonprofit hospice agencies, for-profit hospices had a higher percentage of patients with diagnoses associated with lower skilled-care needs (such as dementia) and longer lengths of stay, according to a study in the February 2 issue of JAMA.
During the past 10 years, the for-profit hospice sector has increased substantially, with a doubling of these types of hospices from 2000 to 2007, while the number of nonprofit hospices has remained essentially ...
After a good night's sleep, people remember information better when they know it will be useful in the future, according to a new study in the Feb. 2 issue of The Journal of Neuroscience. The findings suggest that the brain evaluates memories during sleep and preferentially retains the ones that are most relevant.
Humans take in large amounts of information every day. Most is encoded into memories by the brain and initially stored, but the majority of information is quickly forgotten. In this study, a team of researchers led by Jan Born, PhD, of the University of ...
An analysis of previous studies indicates that compared with chemotherapy alone, use of the cancer drug bevacizumab in combination with chemotherapy or biological therapy is associated with an increased risk of treatment-related death, according to an article in the February 2 issue of JAMA.
A fatal adverse event (FAE) is defined as a death caused in all likelihood by a drug and is a major cause of fatality in the United States. Bevacizumab was approved in combination with chemotherapy for treating many types of advanced cancer, including colorectal cancer, non-small ...
An analysis of data from more than 90,000 Medicare managed care enrollees who received care for rheumatoid arthritis finds that more than one-third did not receive the recommended treatment with a disease-modifying antirheumatic drug, and that receipt varied by demographic factors, socioeconomic status, geographic location and health plan, according to a study in the February 2 issue of JAMA.
Despite evidence-based guidelines recommending early and aggressive treatment of active rheumatoid arthritis (RA), recent population-based studies of disease-modifying antirheumatic ...
SALT LAKE CITY—As day-old embryos, fruit flies called Drosophila enter a stage in which their cells freely divide and proliferate as the insect grows dramatically in size.
This is true for all animals, which undergo most of their growth prior to sexual maturation. Until now, researchers have known nothing about the metabolic state that occurs when cells divide during early development. But in a study published online Tuesday, Feb. 1, 2011, in Cell Metabolism, University of Utah human genetics researchers show that this cell division in Drosophila depends on a metabolic ...
PHILADELPHIA—Medical physicists at Thomas Jefferson University and Jefferson's Kimmel Cancer Center have demonstrated a new real-time tumor tracking technique that can help minimize the amount of radiation delivered to surrounding healthy tissue in a patient—up to 50 percent less in some cases—and maximize the dose the tumor receives.
Respiratory and cardiac motions have been found to displace and deform tumors in the lung, pancreas, liver, breast, and other organs. Because of this, radiation oncologists must expand the margin during radiotherapy. Consequently, a large ...
BOSTON – For-profit hospice agencies had a higher percentage of patients with diagnoses associated with less skilled care and longer lengths of stay (LOS) in hospice, than their nonprofit counterparts, a difference that may leave "nonprofit hospice agencies disproportionately caring for the most costly patients," Beth Israel Deaconess Medical Center researchers report.
The findings appear in the Feb.2 issue of the Journal of the American Medical Association (JAMA).
"There was a big increase in the number of for-profit hospice agencies from 2000 to 2007, and previous ...
